These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35104643)

  • 1. Deep neural networks for neuro-oncology: Towards patient individualized design of chemo-radiation therapy for Glioblastoma patients.
    Ebrahimi Zade A; Shahabi Haghighi S; Soltani M
    J Biomed Inform; 2022 Mar; 127():104006. PubMed ID: 35104643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reinforcement learning for optimal scheduling of Glioblastoma treatment with Temozolomide.
    Ebrahimi Zade A; Shahabi Haghighi S; Soltani M
    Comput Methods Programs Biomed; 2020 Sep; 193():105443. PubMed ID: 32311510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep reinforcement learning for automated radiation adaptation in lung cancer.
    Tseng HH; Luo Y; Cui S; Chien JT; Ten Haken RK; Naqa IE
    Med Phys; 2017 Dec; 44(12):6690-6705. PubMed ID: 29034482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A neuro evolutionary algorithm for patient calibrated prediction of survival in Glioblastoma patients.
    Ebrahimi Zade A; Shahabi Haghighi S; Soltani M
    J Biomed Inform; 2021 Mar; 115():103694. PubMed ID: 33545332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constrained Deep Q-Learning Gradually Approaching Ordinary Q-Learning.
    Ohnishi S; Uchibe E; Yamaguchi Y; Nakanishi K; Yasui Y; Ishii S
    Front Neurorobot; 2019; 13():103. PubMed ID: 31920613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
    Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A
    Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multisource Transfer Double DQN Based on Actor Learning.
    Pan J; Wang X; Cheng Y; Yu Q; Jie Pan ; Xuesong Wang ; Yuhu Cheng ; Qiang Yu ; Yu Q; Cheng Y; Pan J; Wang X
    IEEE Trans Neural Netw Learn Syst; 2018 Jun; 29(6):2227-2238. PubMed ID: 29771674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide and thalidomide in the treatment of glioblastoma multiforme.
    Riva M; Imbesi F; Beghi E; Galli C; Citterio A; Trapani P; Sterzi R; Collice M
    Anticancer Res; 2007; 27(2):1067-71. PubMed ID: 17465245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minibatch Recursive Least Squares Q-Learning.
    Zhang C; Song Q; Meng Z
    Comput Intell Neurosci; 2021; 2021():5370281. PubMed ID: 34659393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two Tier Slicing Resource Allocation Algorithm Based on Deep Reinforcement Learning and Joint Bidding in Wireless Access Networks.
    Chen G; Zhang X; Shen F; Zeng Q
    Sensors (Basel); 2022 May; 22(9):. PubMed ID: 35591186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
    Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
    J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.
    Bell EH; Pugh SL; McElroy JP; Gilbert MR; Mehta M; Klimowicz AC; Magliocco A; Bredel M; Robe P; Grosu AL; Stupp R; Curran W; Becker AP; Salavaggione AL; Barnholtz-Sloan JS; Aldape K; Blumenthal DT; Brown PD; Glass J; Souhami L; Lee RJ; Brachman D; Flickinger J; Won M; Chakravarti A
    JAMA Oncol; 2017 Jun; 3(6):784-792. PubMed ID: 28097324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.
    Affronti ML; Heery CR; Herndon JE; Rich JN; Reardon DA; Desjardins A; Vredenburgh JJ; Friedman AH; Bigner DD; Friedman HS
    Cancer; 2009 Aug; 115(15):3501-11. PubMed ID: 19514083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.
    Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ
    J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypo-fractionated IMRT for patients with newly diagnosed glioblastoma multiforme: a 6 year single institutional experience.
    Ciammella P; Galeandro M; D'Abbiero N; Podgornii A; Pisanello A; Botti A; Cagni E; Iori M; Iotti C
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1609-14. PubMed ID: 23453151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolving role of antiangiogenic therapies in glioblastoma multiforme: current clinical significance and future potential.
    Anthony C; Mladkova-Suchy N; Adamson DC
    Expert Opin Investig Drugs; 2019 Sep; 28(9):787-797. PubMed ID: 31356114
    [No Abstract]   [Full Text] [Related]  

  • 19. Guideline conformity to the Stupp regimen in patients with newly diagnosed glioblastoma multiforme in China.
    Wang Y; Zhang J; Li W; Jiang T; Qi S; Chen Z; Kang J; Huo L; Wang Y; Zhuge Q; Gao G; Wu Y; Feng H; Zhao G; Yang X; Zhao H; Wang Y; Yang H; Kang D; Su J; Li L; Jiang C; Li G; Qiu Y; Wang W; Wang H; Xu Z; Zhang L; Wang R
    Future Oncol; 2021 Nov; 17(33):4571-4582. PubMed ID: 34519220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lumefantrine, an antimalarial drug, reverses radiation and temozolomide resistance in glioblastoma.
    Rajesh Y; Biswas A; Kumar U; Banerjee I; Das S; Maji S; Das SK; Emdad L; Cavenee WK; Mandal M; Fisher PB
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12324-12331. PubMed ID: 32409605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.